Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Neuroendocrine

Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.

234 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Neuroendocrine trial results

Recruiting

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

NCT05583708

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
  • University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
  • City of Hope Duarte, California, United States
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

NCT07006727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • University Of Iowa Iowa City, Iowa, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Corewell Health William Beaum Hosp Royal Oak, Michigan, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Recruiting

A Study of CRD3874-SI in People With Solid Tumors

NCT06021626

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
Locations
  • Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States
  • Washington University St Louis, Missouri, United States
View all 17 locations
View Trial Details

Related conditions